Anti-TRIM24 antibody
Specifications
| Product Cat#: | AB-06-4886 |
| Product type: | Primary antibody |
| Antigen: | TRIM24 |
| Immunogen: | Synthetic peptide within human TRIM24 aa 405-455/1,050. |
| Species immunized: | Rabbit |
| Isotype: | IgG |
| Applications: | Western Blot (1:400); Immunohistochemistry-Paraffin (1:400) |
| Reactivity: | Human |
| Clonality (clone number): | Monoclonal, JE64-31 |
| Form: | Liquid |
| Buffer: | 1*TBS buffer (pH7.4), 0.05% BSA, 40% Glycerol, 0.05% NaN3. |
| Concentration: | 1 mg/ml |
| Purity: | Protein A affinity purified. |
| Storage: | Aliquot and freeze at -20°C. Avoid multiple freeze/thaw cycles. |
| Conjugate: | Unconjugated |
| Alternative names: | E3 ubiquitin protein ligase TRIM24 antibody |
| E3 ubiquitin-protein ligase Trim24 antibody | |
| hTIF1 antibody | |
| PTC6 antibody | |
| RING finger protein 82 antibody | |
| RNF82 antibody | |
| TF1A antibody | |
| TIF1 alpha antibody | |
| TIF1 antibody | |
| TIF1-alpha antibody | |
| TIF1A antibody | |
| TIF1A_HUMAN antibody | |
| TIF1ALPHA antibody | |
| Transcription intermediary factor 1-alpha antibody | |
| Transcriptional intermediary factor 1 alpha antibody | |
| Transcriptional intermediary factor 1 antibody | |
| Trim24 antibody | |
| Tripartite motif containing 24 antibody | |
| Tripartite motif-containing protein 24 antibody |
Show More
Target information
The protein encoded by this gene mediates transcriptional control by interaction with the activation function 2 (AF2) region of several nuclear receptors, including the estrogen, retinoic acid, and vitamin D3 receptors. The protein localizes to nuclear bodies and is thought to associate with chromatin and heterochromatin-associated factors. The protein is a member of the tripartite motif (TRIM) family. The TRIM motif includes three zinc-binding domains – a RING, a B-box type 1 and a B-box type 2 – and a coiled-coil region. Two alternatively spliced transcript variants encoding different isoforms have been described for this gene.
Provider
Erpantech Laboratory
